Ignite Creation Date:
2024-05-05 @ 10:00 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00004075
Status:
COMPLETED
Last Update Posted:
2011-08-03
First Post:
1999-12-10
Brief Title:
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery
Sponsor:
Mayo Clinic
Organization:
Mayo Clinic
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Unspecified Adult Solid Tumor Protocol Specific |
| Lymphoma |
Keywords:
| Name | View |
|---|---|
| unspecified adult solid tumor protocol specific | View |
| recurrent adult Burkitt lymphoma | View |
| recurrent adult diffuse large cell lymphoma | View |
| recurrent adult diffuse mixed cell lymphoma | View |
| recurrent adult diffuse small cleaved cell lymphoma | View |
| recurrent adult Hodgkin lymphoma | View |
| recurrent adult immunoblastic large cell lymphoma | View |
| recurrent adult lymphoblastic lymphoma | View |
| recurrent grade 1 follicular lymphoma | View |
| recurrent grade 2 follicular lymphoma | View |
| recurrent grade 3 follicular lymphoma | View |
| recurrent mantle cell lymphoma | View |
| recurrent adult T-cell leukemialymphoma | View |
| recurrent cutaneous T-cell non-Hodgkin lymphoma | View |
| recurrent mycosis fungoidesSezary syndrome | View |
| recurrent adult grade III lymphomatoid granulomatosis | View |
| recurrent marginal zone lymphoma | View |
| recurrent small lymphocytic lymphoma | View |
| extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue | View |
| nodal marginal zone B-cell lymphoma | View |
| splenic marginal zone lymphoma | View |